Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001213900-26-015382·ARDSLEY ADVISORY PARTNERS LP
Schedule 13G ownership disclosure
ASPIRE BIOPHARMA HLDGS INC
Common Stock · CUSIP: 738920107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Ardsley Advisory Partners LP
Shares: 10,750,000.00 · Class: 7.76%
- Ardsley Advisory Partners GP LLC
Shares: 10,750,000.00 · Class: 7.76%
- Ardsley Partners I GP LLC
Shares: 10,750,000.00 · Class: 7.76%
- Ardsley Partners Advanced Healthcare Fund, L.P.
Shares: 9,229,100.00 · Class: 6.67%
- Ardsley Partners Fund II, L.P.
Shares: 1,520,900.00 · Class: 1.10%
- Philip J. Hempleman
Shares: 10,750,000.00 · Class: 7.76%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-015382
- Form type
- SCHEDULE 13G
- Filer
- ARDSLEY ADVISORY PARTNERS LP
- CIK
- CIK 900529
- Filed
- Feb 12, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership